Results 111 to 120 of about 93,461 (152)
Some of the next articles are maybe not open access.
Avelumab Maintenance for Urothelial Carcinoma
New England Journal of Medicine, 2020To the Editor: Powles et al. (Sept. 24 issue)(1) report the practice-changing results of the JAVELIN Bladder 100 trial, which assessed the advantage of maintenance avelumab therapy plus best supportive care over best supportive care alone with respect to overall survival among patients with advanced urothelial carcinoma who had had a response to first ...
Mollica V., Rizzo A., Massari F.
openaire +4 more sources
ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma
Human Pathology, 2016ARID1A mutation leads to loss of the products of this tumor-suppressor gene. Studies demonstrated ARID1A mutation in 20% of stage IV urothelial carcinomas (UCs) with worse prognosis. The expression of ARID1A in aggressive variants of UC is not studied properly.
Jianhong, Li +4 more
openaire +2 more sources
Epigenetics of Urothelial Carcinoma
2014Urothelial carcinoma is the most frequent type of bladder cancer. Improvements in diagnostics and therapy of this common tumor are urgently required and need to be based on a better understanding of its biology. Epigenetic aberrations are crucial to urothelial carcinoma development and progression.
Wolfgang A, Schulz +3 more
openaire +2 more sources
2023
Our study results showed the specific mortality rate in the endemic area to be 26.3-fold and 7.3- fold the rate recorded in Croatia and Brod- Posavina County, respectively. The mean standardized mortality ratio obtained by indirect standardization yielded an 8-fold and 32-fold risk of death from UUC in the endemic area vs.
CVitković, Ante, Karlović, Krešimir
openaire +1 more source
Our study results showed the specific mortality rate in the endemic area to be 26.3-fold and 7.3- fold the rate recorded in Croatia and Brod- Posavina County, respectively. The mean standardized mortality ratio obtained by indirect standardization yielded an 8-fold and 32-fold risk of death from UUC in the endemic area vs.
CVitković, Ante, Karlović, Krešimir
openaire +1 more source
Erdafitinib in Urothelial Carcinoma
New England Journal of Medicine, 2019Guru, Sonpavde, Gottfrid, Sjödahl
openaire +3 more sources
Molecular classification and diagnostics of upper urinary tract urothelial carcinoma
Cancer Cell, 2021Yoichi Fujii +2 more
exaly